Coverage
-
September 17, 2021
A New Jersey federal judge has approved a $2 million settlement to resolve claims by Indivior PLC investors concerning the drop in the company's stock price following its indictment for downplaying the addictive qualities of its opioid treatment drug, Suboxone.
2 other articles on this case.
View all »